Literature DB >> 1738794

Smokeless tobacco abstinence effects and nicotine gum dose.

D Hatsukami1, D Anton, R Keenan, A Callies.   

Abstract

There were two experiments on abstinence from smokeless tobacco. The purpose of the first experiment was to determine abstinence effects from smokeless tobacco. The purpose of the second experiment was to examine the effects of different doses of nicotine gum on smokeless tobacco abstinence effects. The subjects were male Copenhagen smokeless tobacco users who underwent 3 days of baseline measurement while continuing to use smokeless tobacco ad libitum, and 5 days of the experimental condition. In the first experiment, the subjects were assigned randomly to one of two groups and compared: continuous smokeless tobacco users (n = 10), and deprivation plus no nicotine gum (n = 10). In the second experiment, subjects were assigned randomly and in a double-blind fashion to one of three groups and compared: (1) deprivation plus 0 mg nicotine gum (n = 20); (2) deprivation plus 2 mg nicotine gum (n = 20); and (3) deprivation plus 4 mg nicotine gum (n = 20). The first experiment showed significant increases upon abstinence for the following variables: (1) craving; (2) difficulty concentrating; (3) restlessness; (4) excessive hunger; (5) eating; (6) reaction time; (7) variability of reaction time and (8) total withdrawal scores for both the self-rated and the observer-rated forms. The second experiment showed that nicotine gum failed to significantly reduce smokeless tobacco abstinence effects, although those with high cotinine levels may receive some benefit from nicotine gum.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1738794     DOI: 10.1007/bf02253589

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  32 in total

1.  Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking.

Authors:  P Tønnesen; V Fryd; M Hansen; J Helsted; A B Gunnersen; H Forchammer; M Stockner
Journal:  N Engl J Med       Date:  1988-01-07       Impact factor: 91.245

2.  Saliva cotinine as a measure of smoking status in field settings.

Authors:  D B Abrams; M J Follick; L Biener; K B Carey; J Hitti
Journal:  Am J Public Health       Date:  1987-07       Impact factor: 9.308

3.  Hazards with snuff.

Authors:  D F Goldsmith; D M Winn
Journal:  Lancet       Date:  1980-04-12       Impact factor: 79.321

4.  Evaluation of biochemical validation measures in determination of smoking status.

Authors:  G K Stookey; B P Katz; B L Olson; C A Drook; S J Cohen
Journal:  J Dent Res       Date:  1987-10       Impact factor: 6.116

5.  Cigarette smoking and tobacco usage behavior in children with adolescents: Bogalusa Heart Study.

Authors:  S M Hunter; L S Webber; G S Berenson
Journal:  Prev Med       Date:  1980-11       Impact factor: 4.018

6.  Effect of nicotine on the tobacco withdrawal syndrome.

Authors:  J R Hughes; D K Hatsukami; R W Pickens; D Krahn; S Malin; A Luknic
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Cotinine disposition and effects.

Authors:  N L Benowitz; F Kuyt; P Jacob; R T Jones; A L Osman
Journal:  Clin Pharmacol Ther       Date:  1983-11       Impact factor: 6.875

8.  Self-reports versus sleep laboratory findings in 122 drug-free subjects with complaints of chronic insomnia.

Authors:  M A Carskadon; W C Dement; M M Mitler; C Guilleminault; V P Zarcone; R Spiegel
Journal:  Am J Psychiatry       Date:  1976-12       Impact factor: 18.112

9.  Chewing tobacco use by adolescents: prevalence and relation to cigarette smoking.

Authors:  E Lichtenstein; H H Severson; L S Friedman; D V Ary
Journal:  Addict Behav       Date:  1984       Impact factor: 3.913

Review 10.  Smokeless tobacco: association with increased cancer risk.

Authors:  M E Mattson; D M Winn
Journal:  NCI Monogr       Date:  1989
View more
  7 in total

1.  Chewing tobacco: who uses and who quits? Findings from NHANES III, 1988-1994. National Health and Nutrition Examination Survey III.

Authors:  Beth Howard-Pitney; Marilyn A Winkleby
Journal:  Am J Public Health       Date:  2002-02       Impact factor: 9.308

2.  Physical dependence on nicotine gum: effect of duration of use.

Authors:  D Hatsukami; M Huber; A Callies; K Skoog
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

3.  Effect of oral snus and medicinal nicotine in smokers on toxicant exposure and withdrawal symptoms: a feasibility study.

Authors:  Michael Kotlyar; Louise A Hertsgaard; Bruce R Lindgren; Joni A Jensen; Steven G Carmella; Irina Stepanov; Sharon E Murphy; Stephen S Hecht; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-11-10       Impact factor: 4.254

4.  Waterpipe tobacco and cigarette smoking: direct comparison of toxicant exposure.

Authors:  Thomas Eissenberg; Alan Shihadeh
Journal:  Am J Prev Med       Date:  2009-12       Impact factor: 5.043

5.  Reduced nicotine content cigarettes and nicotine patch.

Authors:  Dorothy K Hatsukami; Louise A Hertsgaard; Rachel I Vogel; Joni A Jensen; Sharon E Murphy; Stephen S Hecht; Steven G Carmella; Mustafa al'Absi; Anne M Joseph; Sharon S Allen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04-19       Impact factor: 4.254

6.  Intranasal Cotinine Plus Krill Oil Facilitates Fear Extinction, Decreases Depressive-Like Behavior, and Increases Hippocampal Calcineurin A Levels in Mice.

Authors:  Nathalie Alvarez-Ricartes; Patricia Oliveros-Matus; Cristhian Mendoza; Nelson Perez-Urrutia; Florencia Echeverria; Alexandre Iarkov; George E Barreto; Valentina Echeverria
Journal:  Mol Neurobiol       Date:  2018-02-27       Impact factor: 5.590

7.  Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation.

Authors:  Dorothy K Hatsukami; Michael Kotlyar; Louise A Hertsgaard; Yan Zhang; Steven G Carmella; Joni A Jensen; Sharon S Allen; Peter G Shields; Sharon E Murphy; Irina Stepanov; Stephen S Hecht
Journal:  Addiction       Date:  2010-02       Impact factor: 6.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.